The sterilization in place bioreactors market is projected to grow from USD 2,339.2 million in 2026 to USD 5,437.0 million by 2036, at a CAGR of 8.8%. Stainless steel SIP bioreactor systems will dominate with a 30.0% market share, while monoclonal antibody manufacturing will lead the applications segment with a 26.0% share.